Wassim Assaad

Wassim Assaad

Auto-generated profile, based on publicly available information

Wassim Assaad

American University of Beirut Faculty of Medicine, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in Multiple Sclerosis Journal – Experimental, Translational and Clinical
Verified
Journal Article
Open access
PDF file
BBBassem I Beirut
Bassem I Beirut
WAWassim Assaad
Wassim Assaad
HTHani Tamim
Hani Tamim
SMSaloua Mrabet
Saloua Mrabet
RGRiyad Goueider
Riyad Goueider
The Middle East North Africa (MENA) region falls in the low-to-moderate multiple sclerosis (MS) prevalence zone, with prevalence rates slightly lower than Southern Europe but much higher than sub-Saharan Africa. However, there is clearly a trend toward increased MS prevalence over the last few decades, consistent with the globally rising prevalence of the disease. We analyzed all data collected from the MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis) registry by the end of December 2018. A total of 6885 patients were eligible for the study. Overall, the clinical phenotype of MS in the MENA region was not different from the Western phenotype except for earlier age at onset and a more aggressive clinical course leading to earlier disability.